劣质药品对“发展中”世界的影响。
Impact of poor-quality medicines in the 'developing' world.
机构信息
Wellcome Trust-Mahosot Hospital-Oxford Tropical Medicine Research Collaboration, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.
出版信息
Trends Pharmacol Sci. 2010 Mar;31(3):99-101. doi: 10.1016/j.tips.2009.11.005. Epub 2010 Feb 1.
Abstract
Since our ancestors began trading several millennia ago, counterfeit and substandard medicines have been a recurring problem, with history punctuated by crises in the supply of anti-microbials, such as fake cinchona bark in the 1600s and fake quinine in the 1800s. Unfortunately this problem persists, in particular afflicting unsuspecting patients in 'developing' countries. Poor-quality drugs are a vital (but neglected) public health problem. They contribute to a 'crevasse' between the enormous effort in therapeutic research and policy decisions and implementation of good-quality medicines.
摘要
自从几千年前我们的祖先开始交易以来，假冒伪劣药品一直是一个反复出现的问题，历史上曾多次出现抗生素供应危机，如 17 世纪的假药金鸡纳树皮和 19 世纪的假药奎宁。不幸的是，这个问题仍然存在，特别是在“发展中”国家中，毫无戒心的患者深受其害。劣质药品是一个至关重要（但被忽视）的公共卫生问题。它们造成了治疗研究和决策以及优质药品实施之间的“裂缝”。
相似文献
1
Impact of poor-quality medicines in the 'developing' world.劣质药品对“发展中”世界的影响。
Trends Pharmacol Sci. 2010 Mar;31(3):99-101. doi: 10.1016/j.tips.2009.11.005. Epub 2010 Feb 1.
2
The primacy of public health considerations in defining poor quality medicines.优先考虑公共卫生因素来定义劣质药品。
PLoS Med. 2011 Dec;8(12):e1001139. doi: 10.1371/journal.pmed.1001139. Epub 2011 Dec 6.
3
Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries.劣质药品：发展中国家高通量检测、全国范围采样和法医学方面的重大挑战。
Analyst. 2011 Aug 7;136(15):3073-82. doi: 10.1039/c0an00627k. Epub 2010 Nov 25.
4
Substandard medicines in resource-poor settings: a problem that can no longer be ignored.资源匮乏地区的劣质药品：一个不容忽视的问题。
Trop Med Int Health. 2008 Aug;13(8):1062-72. doi: 10.1111/j.1365-3156.2008.02106.x. Epub 2008 Jul 8.
5
Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.发展中国家与不合格药品和假药相关的问题：一篇关于自由市场经济中抗逆转录病毒药物时代假药全球影响的综述文章。
East Afr J Public Health. 2008 Dec;5(3):205-10. doi: 10.4314/eajph.v5i3.39004.
6
[Quality of medicines in least developed countries].[最不发达国家的药品质量]
Med Trop (Mars). 2006 Dec;66(6):533-7.
7
Counterfeit and substandard drugs in India may be smaller problem than claimed, say government findings.政府调查结果显示，印度假药和劣药问题或许不像宣称的那么严重。
BMJ. 2014 Jan 7;348:g60. doi: 10.1136/bmj.g60.
8
Substandard and counterfeit medicines.不合格药品和假药。
J Adv Nurs. 2004 May;46(3):338-9.
9
10
Substandard drugs: a potential crisis for public health.不合格药品：对公众健康的潜在危机。
Br J Clin Pharmacol. 2014 Aug;78(2):218-43. doi: 10.1111/bcp.12298.
引用本文的文献
1
Assessing the quality of amoxicillin in the private market in Indonesia: a cross-sectional survey exploring product variety, market volume and price factors.评估印度尼西亚私营市场中阿莫西林的质量：一项探索产品种类、市场规模和价格因素的横断面调查。
BMJ Open. 2025 Jul 22;15(7):e093785. doi: 10.1136/bmjopen-2024-093785.
2
Community pharmacy professionals' knowledge, attitudes, and practices toward substandard and falsified medicines and associated factors in Bahir Dar City, Northwest Ethiopia.埃塞俄比亚西北部巴赫达尔市社区药房专业人员对不合格和假药的知识、态度及做法以及相关因素
Front Pharmacol. 2025 Feb 25;16:1523709. doi: 10.3389/fphar.2025.1523709. eCollection 2025.
3
Making intersectoral stakeholder engagement in medicine quality research work: lessons from the STARmeds study in Indonesia.推动跨部门利益相关者参与医学质量研究工作：来自印度尼西亚STARmeds研究的经验教训。
Health Res Policy Syst. 2025 Feb 19;23(1):21. doi: 10.1186/s12961-025-01286-z.
4
Prevalence and genetic diversity of polymorphisms in , and genes of in southern Côte d'Ivoire.科特迪瓦南部[某种疾病或研究对象]的[相关基因名称]、[相关基因名称]和[相关基因名称]基因多态性的患病率及遗传多样性
Malariaworld J. 2025 Jan 6;16:1. doi: 10.5281/zenodo.14604138. eCollection 2025.
5
A narrative review on problems in product quality, regulatory system constraints, and the concept of quality by design as a solution for quality assurance of African medicines.一篇关于产品质量问题、监管制度限制以及设计质量概念作为非洲药品质量保证解决方案的叙述性综述。
Front Med (Lausanne). 2024 Oct 3;11:1472495. doi: 10.3389/fmed.2024.1472495. eCollection 2024.
6
Perceived Prevalence, Awareness and Attitude towards Counterfeit Medicines among Community Pharmacists of Kathmandu Valley: A Descriptive Cross-sectional Study.加德满都山谷社区药剂师对假药的认知流行率、知晓率和态度：一项描述性横断面研究。
JNMA J Nepal Med Assoc. 2024 Jun 30;62(275):427-432. doi: 10.31729/jnma.8651.
7
Radio frequency identification technology; A method of analysis of falsified pharmaceutical products: Literature review.射频识别技术；假药分析方法：文献综述
SAGE Open Med. 2024 Aug 30;12:20503121241272725. doi: 10.1177/20503121241272725. eCollection 2024.
8
Quality evaluation of selected expired fluoroquinolones medicines obtained from the public hospitals in Jimma zone, Oromia regional state, Ethiopia.对从埃塞俄米亚奥罗米亚州吉马地区公立医院获取的部分过期氟喹诺酮类药物的质量评估
Front Med (Lausanne). 2024 Aug 7;11:1420146. doi: 10.3389/fmed.2024.1420146. eCollection 2024.
9
Modeling and comparison of dissolution profiles for different brands of albendazole boluses.不同品牌阿苯达唑片剂溶出度的建模与比较。
BMC Pharmacol Toxicol. 2024 Aug 9;25(1):48. doi: 10.1186/s40360-024-00774-2.
10
The role of government in the achievement of medicines' security: A preliminary exploration of stakeholders' views and experience.政府在实现药品安全方面的作用：利益相关者观点和经验的初步探索。
PLoS One. 2024 Jun 7;19(6):e0299978. doi: 10.1371/journal.pone.0299978. eCollection 2024.
本文引用的文献
1
Global health-care implications of substandard medicines.不合格药品对全球医疗保健的影响。
Lancet Infect Dis. 2008 Nov;8(11):666. doi: 10.1016/S1473-3099(08)70241-X.
2
Substandard medicines in resource-poor settings: a problem that can no longer be ignored.资源匮乏地区的劣质药品：一个不容忽视的问题。
Trop Med Int Health. 2008 Aug;13(8):1062-72. doi: 10.1111/j.1365-3156.2008.02106.x. Epub 2008 Jul 8.
3
Antimalarial drug quality in the most severely malarious parts of Africa - a six country study.非洲疟疾最严重地区的抗疟药物质量——一项六国研究
PLoS One. 2008 May 7;3(5):e2132. doi: 10.1371/journal.pone.0002132.
4
Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.抗疟药物耐药性选择窗的药代动力学决定因素。
Antimicrob Agents Chemother. 2008 May;52(5):1589-96. doi: 10.1128/AAC.00903-07. Epub 2008 Feb 25.
5
A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia.一项针对东南亚非法假冒青蒿琥酯贸易的联合流行病学调查。
PLoS Med. 2008 Feb;5(2):e32. doi: 10.1371/journal.pmed.0050032.
6
Counterfeit anti-infective drugs.假冒抗感染药物。
Lancet Infect Dis. 2006 Sep;6(9):602-13. doi: 10.1016/S1473-3099(06)70581-3.
7
Manslaughter by fake artesunate in Asia--will Africa be next?亚洲假药青蒿琥酯致人死亡——非洲会步其后尘吗？
PLoS Med. 2006 Jun;3(6):e197. doi: 10.1371/journal.pmed.0030197.
8
Quality and stability of TB medicines: let the buyer beware!结核病药物的质量与稳定性：买家需谨慎！
Int J Tuberc Lung Dis. 2004 Sep;8(9):1043-4.
9
Pharmacopoeial quality of drugs supplied by Nigerian pharmacies.尼日利亚药店所售药品的药典质量。
Lancet. 2001 Jun 16;357(9272):1933-6. doi: 10.1016/s0140-6736(00)05065-0.
10
Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria.简短报告：关于调整伯氨喹剂量以根治间日疟原虫疟疾的思考
Am J Trop Med Hyg. 2000 Mar;62(3):393-5. doi: 10.4269/ajtmh.2000.62.393.
Zotero 插件